Elite Pharmaceuticals Inc (ELTP)

[HGiLS]

Subject: Shareholder Suggestion: Timing of Potential M&A Announcements
Dear Ms. Will,
I hope this email finds you well.
As a long-term shareholder of Elite Pharmaceuticals, Inc. (ELTP), I have followed the company’s progress closely and remain very optimistic about its future, particularly with respect to potential strategic opportunities such as mergers and acquisitions.
I am writing to respectfully request that this suggestion be forwarded to Mr. Nasrat Hakim, President and Chief Executive Officer, for his consideration: In the event of any material announcements related to M&A activities (or other significant corporate developments), please consider releasing them intra-day during regular trading hours (e.g., between 9:30 AM and 4:00 PM ET), rather than after market close or pre-market.
Releasing such news during active trading sessions would help ensure broader market participation, minimize information asymmetry, and potentially catch any short positions (including possibly naked shorts) off-guard, allowing for a more immediate and fair price discovery process that benefits all shareholders.
I understand that announcement timing involves many considerations, including regulatory requirements, coordination with partners, and market conditions, and I appreciate the complexities involved. This is simply offered as constructive input from a supportive investor.
Thank you for your time and for all the excellent work the Elite team continues to do. I look forward to future updates and remain enthusiastic about the company’s prospects.
Best regards,